Abstract
Purpose The global COVID-19 pandemic has accelerated the development of numerous digital technologies in medicine from telemedicine to remote monitoring. Concurrently, the pandemic has resulted in huge pressures on healthcare systems. Medical imaging from chest radiographs to computed tomography and ultrasound of the thorax have played an important role in the diagnosis and management of the coronavirus infection.
Methods We undertook a systematic review of the literature focused on MI in COVID-19 and the utility of AI. Keyword searches were performed on PubMed and preprint servers including arXiv, bioRxiv and medRxiv; 338 papers were included in a meta-analysis and manually reviewed to assess solutions in AI according to their clinical relevance. The maturity of the papers was evaluated based on four criteria: peer-review, patient dataset size, algorithmic complexity and usage of the AI in clinical practice.
Results In the first three quarters of 2020, we identified 3444 papers on MI in COVID-19, of which 556 had at least some focus on AI. 2039 of 3444 were specific to imaging modalities and predominantly (80.7%) focused on CT (9.9% on LUS and 9.5% on CXR). The AI literature was predominantly focused on CXR (51.2%), 36.1% on CT and 1.8% on LUS. Only a small portion of the papers were judged as mature (3.8%) and most AI papers focused on disease detection (72.8%).
Conclusions This review evidences a disparity between clinicians and the AI community, both in the focus on imaging modalities and performed tasks. Better collaboration is needed to allocate resources optimally for the development of clinically relevant solutions that are validated on large-scale patient data.
Clinical implications AI may aid clinicians and radiologists by providing better tools for localization and quantification of disease features and changes thereof, and, with integration of clinical data, may provide better diagnostic performance and prognostic value.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
JB acknowledges funding from the European Union's Horizon 2020 research and innovation programme under grant agreements 826121.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No clinical data was obtained.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author’s contributions: MRZ, DB, JLR, EK and MGA conceived the presented work. MRZ conceived the meta-analysis and supervised this project, and MRZ and MGA set the high-level objectives of this work. JB and MM developed the software to perform paper keyword searches. JB, DM, DR, AC, VM, EK and MGA manually reviewed papers. JB analyzed the results and JB and DR created the figures. All authors contributed toward the interpretation and improvement of the analysis. DB and JB led and distributed the manuscript writing efforts. JB, DB, AC, DR, MGA, EK, DS, PS, MGU and MRZ wrote full, individual sections of the manuscript. All authors reviewed initial versions and contributed significantly to the different sections of the manuscript and approved the submitted version.
Funding Information: None.
Disclosures: No author has a conflict of interests.
Data and code availability: The source code used for the publication keyword search is available via https://pypi.org/project/paperscraper/. A file with the detailed results of the publication meta- analysis is enclosed as Supplementary Material (online only).
Integration of Q3 into meta-analysis. Refactoring manuscript for a more clinically inclined audience.
Data Availability
No clinical data was used.
Abbreviations
- ACR
- (American College of Radiology)
- AI
- (Artificial Intelligence)
- CT
- (Computed Tomography)
- CXR
- (Chest Radiographs)
- DL
- (Deep Learning)
- US
- (Ultrasound)
- LUS
- (Lung Ultrasound)
- MI
- (Medical Imaging)
- PRISMA
- (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)
- RT-PCR
- (Reverse Transcriptase Polymerase Chain reaction)